Ten years of follow-up of bilio-intestinal bypass: is malabsorption necessary for long-term metabolic results?

Abstract

Bilio-intestinal bypass (BIBP) is an uncommon bariatric procedure. In 1999, a prospective trial was started at our institution to evaluate the effectiveness of BIBP. Trial was interrupted in 2006 due to high rate of complications. The aim of the present paper was to retrospectively review 10-year outcomes of BIBP. Retrospective review of bariatric database was performed to find patients that had undergone BIBP from 1999 to 2006. Data collected were as follows: age, gender, body weight, body mass index (BMI), percentage of excess weight loss (%EWL), remission from weight-related diseases, complications, and deaths at 1,3, 5, 7, and 10years. Quality of life was evaluated using "BAROS" questionnaire. From May 1999 to September 2006, 86 patients underwent BIBP. The mean age was 34.9 ± 22.4years, and the initial weight and BMI were 141.2 ± 40.4kg and 49.8 ± 15.5kg/m2, respectively. After 10years, the mean %EWL and BMI were 72.6 ± 18.7 and 31.2 ± 5.6kg/m2. Almost all patients had diarrhea after surgery. Bloating syndrome occurred in 24% of patients, 48% had nephrolithiasis, and 20.9% had cholelithiasis. Remission from diabetes and hypertension was obtained in 75% and 80% of patients. Mortality was 3.2% and reoperation rate was 14.5%. Malabsorption plays a determinant role to obtain a long-lasting treatment for obese patients. However, BIBP is not recommendable due to high rate of complications and metabolic disorders.